ARKAY ARKAY is a pharmaceutical company that develops RK-01, an orally-active pancreatic beta-cell-centric combination product that provides sustained glycemic control for patients with Type 2 diabetes. | ||
Founding Date | Founding Date 2014 | Founding Date 2014 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Windsor, US HQ | Locations Malmö, SE HQ |
Employees | Employees 1 | Employees 9 |